share_log

Pfizer | SC TO-I/A: Third party tender offer statement (Amendment)

Pfizer | SC TO-I/A: Third party tender offer statement (Amendment)

辉瑞 | SC TO-I/A：发行招标公告
美股SEC公告 ·  08/22 11:19

Moomoo AI 已提取核心信息

Pfizer Inc. has announced an amendment to its Tender Offer Statement on Schedule TO, filed with the SEC on August 12, 2024, regarding the Offer to Modify Eligible Performance Share Awards and Eligible Total Shareholder Return Units (TSRUs). The amendment, referred to as Amendment No. 1, supplements the original offer by removing references to continuous employment since July 24, 2024, and clarifying that all active employees of Pfizer and its wholly owned subsidiaries who hold Original Awards and reside in a country where Pfizer has granted Eligible TSRUs and/or Eligible PSAs are eligible to participate. The offer, which commenced on August 12, 2024, allows eligible participants to accept modifications to their performance share awards and TSRUs, potentially extending the performance period and vesting dates, among other changes. The expiration time for the offer is 11:59 p.m., Eastern Time, on September 12, 2024, unless extended. The offer is voluntary, and employees are not required to participate. Pfizer's stock, traded under the symbol 'PFE' on the NYSE, closed at $28.76 per share on August 8, 2024.
Pfizer Inc. has announced an amendment to its Tender Offer Statement on Schedule TO, filed with the SEC on August 12, 2024, regarding the Offer to Modify Eligible Performance Share Awards and Eligible Total Shareholder Return Units (TSRUs). The amendment, referred to as Amendment No. 1, supplements the original offer by removing references to continuous employment since July 24, 2024, and clarifying that all active employees of Pfizer and its wholly owned subsidiaries who hold Original Awards and reside in a country where Pfizer has granted Eligible TSRUs and/or Eligible PSAs are eligible to participate. The offer, which commenced on August 12, 2024, allows eligible participants to accept modifications to their performance share awards and TSRUs, potentially extending the performance period and vesting dates, among other changes. The expiration time for the offer is 11:59 p.m., Eastern Time, on September 12, 2024, unless extended. The offer is voluntary, and employees are not required to participate. Pfizer's stock, traded under the symbol 'PFE' on the NYSE, closed at $28.76 per share on August 8, 2024.
辉瑞公司已在2024年8月12日向美国证券交易委员会提交修订后的Tender Offer Statement on Schedule TO，并对2024年8月12日的投标的修订股东回报单元的申请和股东及表现核心分配的分期奖励进行修订。该修订文件称为修订文件1号，通过删除与2024年7月24日以后的持续雇佣的相关内容和澄清所有持有原始奖励并居住在辉瑞已授予股东回报单元和/或股东及表现核心分配的称职财产所居住国家的辉瑞及其全资拥有子公司的在职员工都有资格参与。这项于2024年8月12日开始的优惠允许有资格的参与者接受对其绩效股奖励和股东回报单元的修改，可能延长绩效期和归属日期等其他更改。优惠的截止时间是2024年9月12日晚上11:59，东部时间，除非延长。该优惠是自愿的，员工不需要参与。辉瑞的股票在纽交所以“PFE”为符号进行交易，并且在2024年8月8日以每股28.76美元的价格收盘。
辉瑞公司已在2024年8月12日向美国证券交易委员会提交修订后的Tender Offer Statement on Schedule TO，并对2024年8月12日的投标的修订股东回报单元的申请和股东及表现核心分配的分期奖励进行修订。该修订文件称为修订文件1号，通过删除与2024年7月24日以后的持续雇佣的相关内容和澄清所有持有原始奖励并居住在辉瑞已授予股东回报单元和/或股东及表现核心分配的称职财产所居住国家的辉瑞及其全资拥有子公司的在职员工都有资格参与。这项于2024年8月12日开始的优惠允许有资格的参与者接受对其绩效股奖励和股东回报单元的修改，可能延长绩效期和归属日期等其他更改。优惠的截止时间是2024年9月12日晚上11:59，东部时间，除非延长。该优惠是自愿的，员工不需要参与。辉瑞的股票在纽交所以“PFE”为符号进行交易，并且在2024年8月8日以每股28.76美元的价格收盘。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

独立文件2  查看翻译

独立文件3  查看翻译

独立文件4  查看翻译

独立文件5  查看翻译

独立文件6  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    热议
    美股
    股票代码最新价涨跌幅

    暂无数据

    资讯热榜
    更新时间